Patient-centered Approaches to the Management of COPD
Wednesday, November 1, 2017
5:30 AM – 7:00 AM
Sheraton Centre Toronto
Grand Centre Room
123 Queen Street West
Toronto, ON M5H 2M9, Canada
5:30 AM – 5:45 AM Registration/Breakfast Served
5:45 AM – 6:45 AM Practitioner’s Edgesm Scientific Session/DecisionSim Case Studies
6:45 AM – 7:00 AM Question & Answer Session/Closing Remarks
Practitioner's Edgesm Panel
Sidney Braman, MD
Professor of Medicine
Pulmonary, Critical Care, and Sleep Medicine
Icahn School of Medicine
New York, New York
Brian W. Carlin, MD, FCCP, MAACVPR, FAARC
Sleep Medicine and Lung Health Consultants
Senior Staff Physician
Pittsburgh Critical Care Associates
Pulmonologists represent the apex of COPD management. They employ a vast knowledge of COPD, including obstructive lung dynamics, lung function testing, and treatment strategies for what is essentially an irreversible disease. A critically important role for this specialist is their stewardship of healthcare providers across various healthcare settings to aid in the improvement of care for patients with COPD. They are the providers who would be able to help other physicians and healthcare providers recommend a best course of action for their patients based on where they are in the continuum of their disease. This program aims to address gaps in COPD care through novel education mechanisms and review strategies that have been shown to be effective in reducing the burden imposed by COPD.
Practitioner’s Edge DecisionSim Format
Practitioner’s Edge is an innovative, discussion-based interactive symposium that provides attendees with cutting-edge medical education in a peer-to-peer discussion format. This Practitioner’s Edge program will feature educational case-based simulations delivered via the DecisionSim platform. DecisionSim is an interactive, cloud-based simulation platform which will allow attendees to engage with a simulated patient through provided iPads.
This educational initiative has been designed for pulmonologists and internal medicine physicians involved in the care of patients with COPD.
Upon completion of this educational activity, participants should be able to:
- Describe a long-term management plan that improves disease monitoring, risk assessment, and exacerbation prevention in patients with COPD
- Review the efficacy and safety of newer bronchodilator therapies and their combinations for patients with COPD
- Select COPD medications and their devices based on the individualized needs of patients with COPD
There is no registration fee for attending this symposium, however, seating is limited.
Preregistration is encouraged to reserve your seat.
For more information or to pre-register for this program click Register Now!
Or call Integrity Continuing Education at 1-855-835-4004
Physician Continuing Medical Education Accreditation Statement
Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Integrity Continuing Education, Inc. designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest (COI)
Integrity Continuing Education, Inc. requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent COI they may have as related to the content of this activity. All identified COI are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
A detailed disclosure for all persons in control of content, including faculty presenters, will be provided at the live event.
The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
This symposium is not sponsored, endorsed, or accredited by the American College of Chest Physicians.
|Provided by Integrity Continuing Education, Inc.|
|Supported by an educational grant from Sunovion Pharmaceuticals, Inc.|